reference/6120096

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6120096

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	2059-0105
issueIdentifier	1
pageRange	120-
publicationName	npj Vaccines
startingPage	120
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c2e50128da78ac0d58a9fe963a6e5496 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fb2ac9502eb7cb3f3aeb91d323d3441d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4568ec531fef0452028a1880a4081979 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c31b910f3d4b9d360d2d51a5c41010e2 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_de92a934abe16816f55bc1b7676bc665 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_42b86fa48892d141d34e108e76f6339b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0558d1eb5e4d9c63aea49736b37d67c6 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5ffb5f0d0de78321df46fc7c93ca64a3
bibliographicCitation	Singh SK, Plieskatt J, Chourasia BK, Singh V, Bengtsson KL, Reimer JM, van Daalen RC, Teelen K, van de Vegte-Bolmer M, van Gemert GJ, Jore MM, Theisen M. Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine. NPJ Vaccines. 2021 Oct 12;6(1):120. PMID: 34642303; PMCID: PMC8511065.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0287-4575 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ce703f6616b69b15aaf96fe6e95c109 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_81cadbc02b8c5540294c14eca37e3862 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91fd60313cce680589be8b50e9094b15 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61ea65eee7a350d6e3011d50a354a028 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c617191f88e5cdc294fd90e31c28967b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0686-370X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63b8e067ab6624b9d8760c68c62caef3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7b1ddf412672b845bbccccf37573690 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf3cf746b49bd7748b13e5b959eb706b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4412-1392 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c73e64364358c9dffeab23f1b6119fff
date	2021-10-12^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1038/s41541-021-00383-8 https://pubmed.ncbi.nlm.nih.gov/PMC8511065 https://pubmed.ncbi.nlm.nih.gov/34642303
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/46172 https://portal.issn.org/resource/ISSN/2059-0105
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8403 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108196

Showing number of triples: 1 to 40 of 40.